(Reuters) - The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could ...

Key market opportunities include advancing rapid, high-throughput testing kits and integrating digital reporting, enhancing multiplex and combination tests, and focusing on at-home diagnostics. The ...

Abbott Laboratories narrowed its full-year outlook as sales of COVID-19 tests slide. COVID-19 test sales in the second quarter dropped 46% from the year before. Second-quarter earnings and revenue ...

Medicare Part B covers COVID-19 tests when conducted in laboratories. Part A may cover lab tests if needed in hospital or skilled nursing facility settings. Since 2023, Medicare has no longer covered ...

NEW YORK, Oct. 8, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The Coronavirus Test Kits Market in APAC size is estimated to grow by USD 2.87 billion from 2024-2028, ...

Medical devices continue to be a strong growth driver for Abbott, as the company battles its ongoing sales slump in diagnostics, which accelerated in the third quarter. Third-quarter revenue for its ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...